Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
Price:
22.91 USD
3.85%
Market Closed
Updated:
May 15, 2024
Arrowhead Pharmaceuticals Inc
Total Other Income
|
Arrowhead Pharmaceuticals Inc
Total Other Income Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
|
Total Other Income
$1.6m
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Total Other Income
-$4.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-204%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Other Income
$252m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Other Income
$151m
|
CAGR 3-Years
126%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Other Income
-$15.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-61%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Other Income
-$31.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Arrowhead Pharmaceuticals Inc's Total Other Income?
Total Other Income
1.6m
USD
1.6m
USD
Based on the financial report for Mar 31, 2024, Arrowhead Pharmaceuticals Inc's Total Other Income amounts to 1.6m USD.
What is Arrowhead Pharmaceuticals Inc's Total Other Income growth rate?
Total Other Income CAGR 10Y
15%
15%
Over the last year, the Total Other Income growth was 714%. The average annual Total Other Income growth rates for Arrowhead Pharmaceuticals Inc have been 48% over the past three years , and 15% over the past ten years .
You don't have any saved screeners yet
